- This event has passed.
February 17, 2021 @ 10:00 am - 11:00 am
According to the new report Diversity and Inclusion in the VC Industry, conducted by Deloitte and NVCA, only 15% women, 15% Asian and Pacific Islanders, 3% African-Americans, and 3% Latinx reach the partner level at VC firms. People of Color are clearly underrepresented in venture capital. This month we look at ways to offset these numbers and increase diversity, equity and inclusion in the life science investment community. Our panelists will discuss:
- Their journey to becoming VCs
- The current state of the VC community
- Advice for increasing diversity in the industry
Terri Cooper, Ph.D., Principal, Vice-Chair External Diversity, Equity & Inclusion, Deloitte
As Deloitte’s Vice Chair of External DEI, Terri focuses on fostering Deloitte’s external brand and helping to drive market facing efforts. Dr. Cooper believes each and every individual has a role to play in creating an inclusive culture, and, when she served as Deloitte’s Chief Inclusion Officer, she instilled Deloitte’s Six Signature Traits of an Inclusive Leader – such as cultural intelligence and cognizance of bias – across the organization.
Margarita Chavez, JD, Managing Director, AbbVie Ventures at AbbVie
Margarita is Managing Director at Abbvie Ventures. Margarita has led investments in over a dozen biotech companies in the US and Europe. She is responsible for AbbVie Ventures’ investments in Alector, Morphic Therapeutics, CARISMA Therapeutics, and Jnana Therapeutics, among others. Margarita brings over 20 years of dealmaking experience, with over a decade of biotech licensing, IPOs and acquisitions. As a Director with Abbott’s Global Pharmaceutical Licensing & Acquisitions, she was involved in the in-licensing of Elagolix, the acquisition of Solvay and Immuven, and the acquisition of the Lupron franchise.
Diane Yoo, MBA, Managing Partner, Medingenii Capital
Diane Yoo is a results-driven entrepreneur, venture capitalist and angel investor with more than 15+ years of experience. As an accredited investor, she has invested in 30+ companies and is passionate about empowering women and diversity investors and founders. With only 1% of Asian females leading as Partner or Founder in Venture Capital, Diane is the first woman General Partner for Medtech and Healthtech venture capital in the heart of the largest medical center of the world, Texas Medical Center. With a proven track record, she is a seasoned expert as founder and partner to several investment funds and investment networks.
Juan Cueva, MBA, PhD, Senior Associate, Action Potential Venture Capital
Juan Cueva is a Senior Associate with Action Potential Venture Capital in Palo Alto, CA. He is currently a Board Observed with APVC portfolio companies Presidio and Cala. Juan was previously an Investment Manager with Applied Ventures, the venture arm of Applied Materials, the semiconductor equipment company. At Applied Ventures, Juan led investments in technologies at the intersection of life science and advanced material engineering. Juan served as Board Observer for Applied Ventures portfolio companies Ultivue, Exo Imaging, and Ontera.